180 related articles for article (PubMed ID: 35208235)
1. An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice.
Sato Y; Yamaguchi M; Kashiwakura I
Metabolites; 2022 Feb; 12(2):. PubMed ID: 35208235
[TBL] [Abstract][Full Text] [Related]
2. Proteomic changes by radio-mitigative thrombopoietin receptor agonist romiplostim in the blood of mice exposed to lethal total-body irradiation.
Nishida T; Yamaguchi M; Tatara Y; Kashiwakura I
Int J Radiat Biol; 2020 Sep; 96(9):1125-1134. PubMed ID: 32602419
[TBL] [Abstract][Full Text] [Related]
3. Diverse functions of the thrombopoietin receptor agonist romiplostim rescue individuals exposed to lethal radiation.
Yamaguchi M; Hirouchi T; Yoshioka H; Watanabe J; Kashiwakura I
Free Radic Biol Med; 2019 May; 136():60-75. PubMed ID: 30926566
[TBL] [Abstract][Full Text] [Related]
4. The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation.
Yamaguchi M; Kashiwakura I
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238707
[TBL] [Abstract][Full Text] [Related]
5. The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation.
Yamaguchi M; Hirouchi T; Yokoyama K; Nishiyama A; Murakami S; Kashiwakura I
Sci Rep; 2018 Jul; 8(1):10659. PubMed ID: 30006622
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Antioxidant Stress-Responsive Transcription Factor Nrf2 Target Gene in the Reduction of Radiation Damage by the Thrombocytopenia Drug Romiplostim.
Chiba A; Kawabata N; Yamaguchi M; Tokonami S; Kashiwakura I
Biol Pharm Bull; 2020; 43(12):1876-1883. PubMed ID: 33268705
[TBL] [Abstract][Full Text] [Related]
7. Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation.
Hirouchi T; Ito K; Nakano M; Monzen S; Yoshino H; Chiba M; Hazawa M; Nakano A; Ishikawa J; Yamaguchi M; Tanaka K; Kashiwakura I
Curr Pharm Biotechnol; 2015; 17(2):190-9. PubMed ID: 26306743
[TBL] [Abstract][Full Text] [Related]
8. Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome.
Yamaguchi M; Suzuki M; Funaba M; Chiba A; Kashiwakura I
Stem Cell Res Ther; 2020 Aug; 11(1):339. PubMed ID: 32746943
[TBL] [Abstract][Full Text] [Related]
9. Romiplostim (Nplate
Bunin DI; Bakke J; Green CE; Javitz HS; Fielden M; Chang PY
Int J Radiat Biol; 2020 Jan; 96(1):145-154. PubMed ID: 31021662
[No Abstract] [Full Text] [Related]
10. Single-Dose Administration of Recombinant Human Thrombopoietin Mitigates Total Body Irradiation-Induced Hematopoietic System Injury in Mice and Nonhuman Primates.
Xing S; Shen X; Yang JK; Wang XR; Ou HL; Zhang XW; Xiong GL; Shan YJ; Cong YW; Luo QL; Yu ZY
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1357-1367. PubMed ID: 32758640
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of the c-mpl Agonist Romiplostim on Megakaryocytopoiesis of Human CD34
Monzen S; Kimura S; Yamaguchi M; Kashiwakura I
J Interferon Cytokine Res; 2018 May; 38(5):206-212. PubMed ID: 29708814
[TBL] [Abstract][Full Text] [Related]
12. Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule.
Bunin DI; Javitz HS; Gahagen J; Bakke J; Lane JH; Andrews DA; Chang PY
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):705-717. PubMed ID: 37224926
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation.
Wang C; Zhang B; Wang S; Zhang J; Liu Y; Wang J; Fan Z; Lv Y; Zhang X; He L; Chen L; Xia H; Li Y; Pei X
Sci Rep; 2015 Sep; 5():12993. PubMed ID: 26403418
[TBL] [Abstract][Full Text] [Related]
14. Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.
Mouthon MA; Gaugler MH; Van der Meeren A; Vandamme M; Gourmelon P; Wagemaker G
Exp Hematol; 2001 Jan; 29(1):30-40. PubMed ID: 11164103
[TBL] [Abstract][Full Text] [Related]
15. Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin.
Van der Meeren A; Mouthon MA; Gaugler MH; Vandamme M; Gourmelon P
Radiat Res; 2002 Jun; 157(6):642-9. PubMed ID: 12005542
[TBL] [Abstract][Full Text] [Related]
16. Radioprotective and radiomitigative effects of BP-C2, a novel lignin-derived polyphenolic composition with ammonium molybdate, in two mouse strains exposed to total body irradiation.
Bykov VN; Drachev IS; Kraev SY; Maydin MA; Gubareva EA; Pigarev SE; Anisimov VN; Baldueva IA; Fedoros EI; Panchenko AV
Int J Radiat Biol; 2018 Feb; 94(2):114-123. PubMed ID: 29251085
[TBL] [Abstract][Full Text] [Related]
17. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
Kirito K; Komatsu N
Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.
Kuter DJ; Mufti GJ; Bain BJ; Hasserjian RP; Davis W; Rutstein M
Blood; 2009 Oct; 114(18):3748-56. PubMed ID: 19671919
[TBL] [Abstract][Full Text] [Related]
19. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
20. Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
Lee JW; Lee SE; Jung CW; Park S; Keta H; Park SK; Kim JA; Oh IH; Jang JH
Lancet Haematol; 2019 Nov; 6(11):e562-e572. PubMed ID: 31474546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
